Privium Fund Management B.V. acquired a new position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) in the 3rd quarter, Holdings Channel.com reports. The fund acquired 20,023 shares of the biopharmaceutical company’s stock, valued at approximately $3,546,000. Alnylam Pharmaceuticals accounts for about 1.1% of Privium Fund Management B.V.’s holdings, making the stock its […]